The assessment of quality of life as a primary outcome in cancer clinical trials is now almost universal. Such data are necessarily longitudinal and multidimensional, and are often severely unbalanced by missing values or early patient death. However, to date, their reporting in the applied literature has generally used simple descriptive summaries that ignore many of these complexities. Not only can these be misleading, but they generally do not allow firm conclusions to be drawn about a major endpoint. The aim of this thesis is to assess the practical application of recent developments in statistical methodology for the analysis of quality of life data collected using self assessment questionnaires within cancer clinical trials. Its empha...
The health-related quality of life is a major objective in oncology clinical trials to improve patie...
The major end-points arising from cancer clinical trials are reviewed. These are: tumour response, t...
Over the past two decades, quality of life (QoL) research has become an integral endpoint in clinica...
The assessment of quality of life as a primary outcome in cancer clinical trials is now al...
The aim of the thesis is to critically review, apply and where appropriate develop statistical metho...
Abstract Background The use of health-related quality of life (HRQoL) as an endpoint in cancer clini...
Quality of Life (QL) is now included as an endpoint in many phase III cancer clinical trials. Numero...
PosterInternational audienceThe health-related quality of life (HRQoL) has become one of priority ob...
The measurement of patient-reported outcomes, including health-related quality of life, is a new ini...
We summarize issues that arise when considering quality of life (QOL) data in cancer clinical trials...
Classical end-points in clinical therapeutic trials in oncology are usually defined by total, recurr...
Background Health-related quality of life is a topic of current interest. This paper...
A simple instrument for self-assessment of quality of life (QL) in patients with cancer was elaborat...
Survival and quality of life are the two end-points of cancer treatment. Recommendations are availab...
International audienceBackground: Health-Related Quality of Life (HRQoL) is an important endpoint in...
The health-related quality of life is a major objective in oncology clinical trials to improve patie...
The major end-points arising from cancer clinical trials are reviewed. These are: tumour response, t...
Over the past two decades, quality of life (QoL) research has become an integral endpoint in clinica...
The assessment of quality of life as a primary outcome in cancer clinical trials is now al...
The aim of the thesis is to critically review, apply and where appropriate develop statistical metho...
Abstract Background The use of health-related quality of life (HRQoL) as an endpoint in cancer clini...
Quality of Life (QL) is now included as an endpoint in many phase III cancer clinical trials. Numero...
PosterInternational audienceThe health-related quality of life (HRQoL) has become one of priority ob...
The measurement of patient-reported outcomes, including health-related quality of life, is a new ini...
We summarize issues that arise when considering quality of life (QOL) data in cancer clinical trials...
Classical end-points in clinical therapeutic trials in oncology are usually defined by total, recurr...
Background Health-related quality of life is a topic of current interest. This paper...
A simple instrument for self-assessment of quality of life (QL) in patients with cancer was elaborat...
Survival and quality of life are the two end-points of cancer treatment. Recommendations are availab...
International audienceBackground: Health-Related Quality of Life (HRQoL) is an important endpoint in...
The health-related quality of life is a major objective in oncology clinical trials to improve patie...
The major end-points arising from cancer clinical trials are reviewed. These are: tumour response, t...
Over the past two decades, quality of life (QoL) research has become an integral endpoint in clinica...